Publications by authors named "Guy Boudreau"

Claim this Profile
O
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM.
Guy Boudreau, Ian Finkelstein, Corrie Graboski, May Ong, Suzanne Christie

Can J Neurol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.
Werner J Becker, Guy Boudreau, Ian Finkelstein, Corrie Graboski, May Ong

Can J Neurol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.
Guy Boudreau, Ian Finkelstein, Corrie Graboski, May Ong, Suzanne Christie

Can J Neurol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
Messoud Ashina, Stewart J Tepper, Jan Lewis Brandes, Uwe Reuter, Guy P Boudreau

Headache· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
Todd Schwedt, Uwe Reuter, Stewart Tepper, Messoud Ashina, David Kudrow, Guy P Boudreau

J Headache Pain· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, Uwe Reuter, Guy Boudreau

Cephalalgia· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurostimulation for Refractory Cervicogenic Headache: A Three-Year Retrospective Study.
Marzieh Eghtesadi, Elizabeth Leroux, Marie-Pierre Fournier-Gosselin, Paul Lespérance, Luc Marchand, Guy Pierre Boudreau

Neuromodulation· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled Trial.
Elizabeth Leroux, Line Beaudet, Guy Boudreau, Marzieh Eghtesadi, Luc Marchand

Headache· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.
Guy P Boudreau, Brian M Grosberg, Peter J McAllister, Richard B Lipton, Dawn C Buse

Int J Gen Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin for the management of cervicogenic headache: a double blind study.
Guy P Boudreau, Luc Marchand

Can J Neurol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A as treatment for frequent headache and cervical pain: a retrospective study of 236 patients.
Guy Boudreau, Emran Aghai, Luc Marchand

Pain Res Manag· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis